← Leaderboards
George Henry De Vries
Loyola University Chicago
$1,219,718
Attributed
$1,219,718
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $314.3K · FY2005–15$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$1,219,718 · 3
VA$0 · 2
By mechanism
R01$1,194,718 · 1
R13$25,000 · 2
I01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Loyola University Chicago
Same institution · by research overlap
- William A Wolf$1,670,120
Others in their field
Top investigators on “Multiple Sclerosis”
- David A. Hafler · Brigham And Women'S Hospital$33,720,341
- Vijay K Kuchroo · Brigham And Women'S Hospital$32,935,587
- Stephen L Hauser · University Of California San Francisco$32,469,388
- Katerina Akassoglou · University Of California San Diego$24,525,425
- Abdolmohamad Rostami · Thomas Jefferson University$23,969,638
- Stephen D Miller · Northwestern University$23,969,272
Research focus
Multiple SclerosisAxonSeriesNeuronsNeurogenesisResearch StudyDemyelinating DiseasesDisease RemissionInflammatoryInflammationAffectInjection Of Therapeutic AgentRecoveryRepairedBaseCell ProliferationChronicCytokineEnvironmentExperimental Autoimmune EncephalomyelitisImmuneInfiltrationCell Cell InteractionTissue /Cell Culture
Grant awards (12)
The Potential of Didox as an Oral Therapy for Multiple Sclerosis$0
I01 · FY2015 · VA · contact PI
The Potential of Didox as an Oral Therapy for Multiple Sclerosis$0
I01 · FY2014 · VA · contact PI
Promotion of Functional Recovery From Demylinating Disease$0
I01 · FY2014 · VA · contact PI
The Potential of Didox as an Oral Therapy for Multiple Sclerosis$0
I01 · FY2013 · VA · contact PI
Promotion of Functional Recovery From Demylinating Disease$0
I01 · FY2009 · VA · contact PI
Axonal Oligodendrocyte Signaling in Multiple Sclerosis$292,218
R01 · FY2006 · NS · contact PI
Axonal Oligodendrocyte Signaling in Multiple Sclerosis$299,250
R01 · FY2005 · NS
American Society for Neurochemistry: Annual Conference Grant$15,000
R13 · FY2005 · NS
Axonal Oligodendrocyte Signaling in Multiple Sclerosis$212,712
R01 · FY2004 · NS
Axonal Oligodendrocyte Signaling in Multiple Sclerosis$88,913
R01 · FY2004 · NS
Cellular and Molecular Mechanisms of Neural Development$10,000
R13 · FY2004 · NS
Axonal Oligodendrocyte Signaling in Multiple Sclerosis$301,625
R01 · FY2003 · NS